IL-8 and LYPD8 expression levels are associated with the inflammatory response in the colon of patients with ulcerative colitis

Okada,Tomoyuki; Kanda,Tsutomu; Ueda,Naoki; Ikebuchi,Yuichiro; Hashiguchi,Keiichi; Nakao,Kazuhiko; Isomoto,Hajime

doi:10.3892/br.2020.1280

IL-8 and LYPD8 expression levels are associated with the inflammatory response in the colon of patients with ulcerative colitis

Authors:
- Tomoyuki Okada
- Tsutomu Kanda
- Naoki Ueda
- Yuichiro Ikebuchi
- Keiichi Hashiguchi
- Kazuhiko Nakao
- Hajime Isomoto
View Affiliations

Affiliations: Division of Medicine and Clinical Science, Faculty of Medicine Tottori University, Yonago, Tottori 683‑8504, Japan, Department of Gastroenterology and Hepatology, Nagasaki University Hospital, Nagasaki 852‑8501, Japan
Published online on: February 20, 2020 https://doi.org/10.3892/br.2020.1280
Pages: 193-198

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ulcerative colitis (UC) is an idiopathic chronic inflammatory disorder affecting the large intestine, which may involve mucosal degeneration. Glycoproteins, mucin2 (MUC2) and the LY6/PLAUR domain containing 8 (LYPD8) are present on the mucous layer of the colon and can hinder the invasion of bacteria, thus contributing to the prevention of colitis. The present study investigated the expression levels of interleukin‑8 (IL‑8), MUC2 and LYPD8 on the mucous membranes of patients with UC. A total of 18 patients with UC (6 females and 12 males) were examined. Biopsies of the lesions as well as matching normal membranes were obtained and the mRNA expression levels of IL‑8, MUC2 and LYPD8 were compared. LYPD8 expression was downregulated in the lesions and the relapsing‑remitting subtype of lesions was associated with higher levels of MUC2 expression compared with single attack and chronic lesions subtypes. A positive correlation between Matts' histopathological grade and IL‑8, as well as a negative correlation between Matts' histopathological grade and LYPD8 were observed. The expression levels of LYPD8 were lower in highly active lesions and these levels decreased according to the intensity of the mucosal inflammation. Conversely, an increase in MUC2 expression levels may reflect the recovery of the outer mucus layer in the remission phase. Therefore, the examination of MUC2 and LYPD8 expression levels may be useful indicators of mucosal healing in patients with UC.

View Figures

View References

1	Tindall WN, Boltri JM and Wilhelm SM: Mild-to-moderate ulcerative colitis: Your role in patient compliance and health care costs. J Manag Care Pharm. 13((7 Suppl A)): S2–S12; quiz S13-S14. 2007.PubMed/NCBI View Article : Google Scholar
2	International Agency for Research on Cancer (IARC): Cancer Tomorrow. Estimated number of incident cases from 2018 to. 2040, colon both sexes, all ages. IARC, Lyon, 2018. http://gco.iarc.fr/tomorrow/graphic-line?type=0&population=900&mode=population&sex=0&cancer=39&age_group=value&apc_male=0&apc_female=0.
3	Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T III, McLeod R, et al: AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 138:738–745. 2010.PubMed/NCBI View Article : Google Scholar
4	Tranter-Entwistle I, Mullaney TG, Noah K, Pearson J, Falvey J, Gearry R and Eglinton T: Long-term incidence of dysplasia and colorectal cancer in an ulcerative colitis population-based cohort. ANZ J Surg: Jan 23, 2020 (Epub ahead of print).
5	Sartor RB: Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 3:390–407. 2006.PubMed/NCBI View Article : Google Scholar
6	Dorofeyev AE, Vasilenko IV, Rassokhina OA and Kondratiuk RB: Mucosal barrier in ulcerative colitis and Crohn's disease. Gastroenterol Res Pract. 2013(431231)2013.PubMed/NCBI View Article : Google Scholar
7	Kawashima H: Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer. Biol Pharm Bull. 35:1637–1641. 2012.PubMed/NCBI View Article : Google Scholar
8	Okumura R, Kurakawa T, Nakano T, Kayama H, Kinoshita M, Motooka D, Gotoh K, Kimura T, Kamiyama N, Kusu T, et al: Lypd8 promotes the segregation of flagellated microbiota and colonic epithelia. Nature. 532:117–121. 2016.PubMed/NCBI View Article : Google Scholar
9	Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, Punit S, Karlsson M, Bry L, Glickman JN, et al: Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous maternally transmitted colitis. Cell Host Microbe. 8:292–300. 2010.PubMed/NCBI View Article : Google Scholar
10	Mukhopadhya I, Hansen R, El-Omar EM and Hold GL: IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol. 9:219–230. 2012.PubMed/NCBI View Article : Google Scholar
11	Hansen R, Thomson JM, Fox JG, El-Omar EM and Hold GL: Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Med Microbiol. 61:1–14. 2011.PubMed/NCBI View Article : Google Scholar
12	Pearl DS, Shah K, Whittaker MA, Nitch-Smith H, Brown JF, Shute JK and Trebble TM: Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity. J Crohns Colitis. 7:481–489. 2013.PubMed/NCBI View Article : Google Scholar
13	Tytgat KM, van der Wal JW, Einerhand AW, Büller HA and Dekker J: Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun. 224:397–405. 1966.PubMed/NCBI View Article : Google Scholar
14	Matts SG: The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med. 30:393–407. 1961.PubMed/NCBI
15	World Medical Association: World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 310: 2191.2194, 2013.
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
17	Bruno ME, Rogier EW, Arsenescu RI, Flomenhoft DR, Kurkjian CJ, Ellis GI and Kaetzel CS: Correlation of biomarker expression in colonic mucosa with disease phenotype in Crohn's disease and ulcerative colitis. Dig Dis Sci. 60:2976–2984. 2015.PubMed/NCBI View Article : Google Scholar
18	Lin X, Li J, Zhao Q, Feng JR, Gao Q and Nie JY: WGCNA reveals key roles of IL8 and MMP-9 in progression of involvement area in colon of patients with ulcerative colitis. Curr Med Sci. 38:252–258. 2018.PubMed/NCBI View Article : Google Scholar
19	Korolkova OY, Myers JN, Pellom ST, Wang L and M'Koma AE: Characterization of serum cytokine profile in predominantly colonic inflammatory bowel disease to delineate ulcerative and Crohn's colitides. Clin Med Insights Gastroenterol. 8:29–44. 2015.PubMed/NCBI View Article : Google Scholar
20	Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA and Mueller C: Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol. 144:997–1007. 1994.PubMed/NCBI
21	Dkhil MA: Sex-determined susceptibility and differential MUC2 mRNA expression during the course of murine intestinal eimeriosis. Parasitol Res. 114:283–288. 2015.PubMed/NCBI View Article : Google Scholar
22	Niv Y: Mucin gene expression in the intestine of ulcerative colitis patients: A systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 28:1241–1245. 2016.PubMed/NCBI View Article : Google Scholar
23	Neurath MF and Travis SP: Mucosal healing in inflammatory bowel diseases: A systematic review. Gut. 61:1619–1635. 2012.PubMed/NCBI View Article : Google Scholar
24	Papi C and Aratari A: Mucosal healing as a treatment for IBD? Expert Rev Gastroenterol Hepatol. 8:457–459. 2014.PubMed/NCBI View Article : Google Scholar
25	Shah SC, Colombel JF, Sands BE and Narula N: Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 14:1245–1255.e8. 2016.PubMed/NCBI View Article : Google Scholar
26	D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J and Sutherland LR: A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 132:763–786. 2007.PubMed/NCBI View Article : Google Scholar
27	Rosenberg L, Nanda KS, Zenlea T, Gifford A, Lawlor GO, Falchuk KR, Wolf JL, Cheifetz AS, Goldsmith JD and Moss AC: Histologic markers of inflammation in patients with ulcerative colitis in clinical remission. Clin Gastroenterol Hepatol. 11:991–996. 2013.PubMed/NCBI View Article : Google Scholar
28	Mazzuoli S, Guglielmi FW, Antonelli E, Salemme M, Bassotti G and Villanacci V: Definition and evaluation of mucosal healing in clinical practice. Dig Liver Dis. 45:969–977. 2013.PubMed/NCBI View Article : Google Scholar